Last reviewed · How we verify
GVGH Shigella sonnei 1790GAHB vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
GVGH Shigella sonnei 1790GAHB vaccine (GVGH Shigella sonnei 1790GAHB vaccine) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GVGH Shigella sonnei 1790GAHB vaccine TARGET | GVGH Shigella sonnei 1790GAHB vaccine | GlaxoSmithKline | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GVGH Shigella sonnei 1790GAHB vaccine CI watch — RSS
- GVGH Shigella sonnei 1790GAHB vaccine CI watch — Atom
- GVGH Shigella sonnei 1790GAHB vaccine CI watch — JSON
- GVGH Shigella sonnei 1790GAHB vaccine alone — RSS
Cite this brief
Drug Landscape (2026). GVGH Shigella sonnei 1790GAHB vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/gvgh-shigella-sonnei-1790gahb-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab